Botulinum toxin therapy for cervical dystonia
- PMID: 14580035
- DOI: 10.1016/s1047-9651(03)00045-7
Botulinum toxin therapy for cervical dystonia
Abstract
Botulinum toxin revolutionized the treatment of cervical dystonia. In contrast to systemically active medications, the effect of botulinum toxin results from selective administration to weaken muscles involved in the dystonic posturing of the head. This article reviews the pathophysiologic basis of symptoms in cervical dystonia and how botulinum toxin alleviates them. Other therapeutic options are reviewed for comparison. This article discusses strategies for maximizing the clinical benefit of botulinum toxin in this disorder and reviews muscle selection and identification with electromyography.
Similar articles
-
Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.Parkinsonism Relat Disord. 2012 Jul;18(6):731-6. doi: 10.1016/j.parkreldis.2012.04.005. Epub 2012 May 8. Parkinsonism Relat Disord. 2012. PMID: 22575237
-
Botulinum toxin treatment of axial and cervical dystonia.Disabil Rehabil. 2007 Dec 15;29(23):1769-77. doi: 10.1080/01421590701568262. Disabil Rehabil. 2007. PMID: 18033602 Review.
-
Utility of an EMG mapping study in treating cervical dystonia.Muscle Nerve. 2000 Nov;23(11):1752-6. doi: 10.1002/1097-4598(200011)23:11<1752::aid-mus12>3.0.co;2-u. Muscle Nerve. 2000. PMID: 11054755 Clinical Trial.
-
Outcome of selective ramisectomy for botulinum toxin resistant torticollis.J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):472-8. doi: 10.1136/jnnp.65.4.472. J Neurol Neurosurg Psychiatry. 1998. PMID: 9771768 Free PMC article.
-
Role of botulinum toxin in the treatment of cervical dystonia.Neurol Clin. 2008 May;26 Suppl 1:43-53. doi: 10.1016/s0733-8619(08)80004-7. Neurol Clin. 2008. PMID: 18603167 Review. No abstract available.
Cited by
-
The Collicular-Pulvinar-Amygdala Axis and Adult-Onset Idiopathic Focal Dystonias.Adv Neurobiol. 2023;31:195-210. doi: 10.1007/978-3-031-26220-3_11. Adv Neurobiol. 2023. PMID: 37338703
-
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study.Neuropsychiatr Dis Treat. 2018 Apr 26;14:1119-1124. doi: 10.2147/NDT.S152252. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29731634 Free PMC article.
-
Botulinum toxin type A products are not interchangeable: a review of the evidence.Biologics. 2014 Oct 6;8:227-41. doi: 10.2147/BTT.S65603. eCollection 2014. Biologics. 2014. PMID: 25336912 Free PMC article. Review.
-
Use of botulinum toxin for movement disorders.Drugs Context. 2019 Jun 18;8:212586. doi: 10.7573/dic.212586. eCollection 2019. Drugs Context. 2019. PMID: 31258617 Free PMC article. Review.
-
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom.Clinicoecon Outcomes Res. 2017 Apr 15;9:211-229. doi: 10.2147/CEOR.S112254. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 28458568 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources